Utilisation review of clopidogrel: Are they used under the FDA-approved indications?

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 9, 2007, Pages 1031-1037

  Niruntraporn, Surachet ^a   Chaiyakunapruk, Nathorn ^a   Nathisuwan, Surakit ^b   Thamlikitkul, Visanu ^c  

^a NARESUAN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Clopidogrel; Drug use evaluation; Utilisation review

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ACUTE CORONARY SYNDROME; ADULT; AGED; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG USE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; OUTPATIENT; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; THAILAND;

ACUTE CORONARY SYNDROME; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ASPIRIN; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; MEDICAL RECORDS; MIDDLE AGED; OUTPATIENTS; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; THAILAND; TICLOPIDINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34548709759     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1429     Document Type: Review

References (26)

1. Smith SC, Jr. Feldman TE, Hirshfeld JW, Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention), 2005. Available at: http://www.acc.org/clinical/guidelines/percutaneous/update/ index.pdf
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction), 2004. Available at www.acc.org/clinical/guidelines/stemi/ index.pdf
3. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with unstable angina), 2002. Available at: http://www.acc.org/clinical/guidelines/ unstable/unstable.pdf
4. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/pad/index.pdf
5. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577-617.
6. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for the management of patients with chronic stable angina), 2002. Available at www.acc.org/clinical/guidelines/stable/stable.pdf
7. Harrington RA, Becker RC, Ezekowitz M, et al. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: S513-S548.
8. Albers G, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: S483-S512.
9. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827-830.
10. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
11. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. Br Med J 2000; 321: 1183-1187.
12. Plavix (Clopidogrel bisulfate) tablet [homepages on the internet]. Maryland (MD). Center for Drug Evaluation and Research [Revised 2001, June; cited 2006 February 14]. Available at http://www.fda.gov/cder/foi/ nda/2002/20-839S019_Clopidogrel%20Bisulfate∥ntlbl.pdf
13. CAPRIE steering committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
14. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
15. Peters RJ, Mehta SR. Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 2003; 108: 1682-1687.
16. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533.
17. Steinhubl SR, Berger PB, Mann JT, III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411-2420 [Erratum in: JAMA. 26 Feb 2003; 289(8): 987].
18. Sabatine MS, Cannon CP, Gibson M, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial Infarction with ST-segment elevation. N Engl J Med 2005; 352: 1179-1189.
19. COMMIT collaborative group. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607-1621.
20. Harker LA, Boissel JP, Pilgrim AJ, et al. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf 1999; 21: 325-335.
21. Fork FT, Lafolie P, Toth E, Lindgarde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325mg aspirin in healthy volunteers: a gastroscopic study. Scand J Gastroenterol 2000; 35: 464-469.
22. Kubler PA, Pillans PI, Marrinan MC, et al. Concordance between clopidogrel use and prescribing guidelines. Intern Med J 2004; 34: 663-667.
23. Savonitto S, Ambrosini V, Marzocchi A, et al. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian drug evaluation in angioplasty (IDEA) study. Ital Heart J 2005; 6: 106-118.
24. Bland M. An introduction to Medical Statistics, 2nd edn. Oxford University Press: New York, NY, 1999; 374.
25. Smith SC, Jr. Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation 2001; 104: 1577-1579.
26. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331-337.